The GEO Group, Inc. (NYSE:GEO – Free Report) – Equities researchers at Sidoti Csr raised their Q1 2024 earnings per share estimates for shares of The GEO Group in a research report issued on Thursday, April 11th. Sidoti Csr analyst B. Mccarthy now forecasts that the real estate investment trust will post earnings of $0.21 […]
Traws Pharma, Inc. (NASDAQ:TRAW – Free Report) – Investment analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for shares of Traws Pharma in a note issued to investors on Wednesday, April 3rd. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings of ($0.24) per share for the quarter. […]
Alliance Resource Partners, L.P. (NASDAQ:ARLP – Free Report) – Stock analysts at Noble Financial cut their Q1 2024 EPS estimates for shares of Alliance Resource Partners in a research note issued to investors on Thursday, April 11th. Noble Financial analyst M. Reichman now forecasts that the energy company will post earnings per share of $0.97 […]
LOWELL, Ark., April 16, 2024--J.B. Hunt Transport Services, Inc. (NASDAQ: JBHT) announced first quarter 2024 U.S. GAAP (United States Generally Accepted Accounting Principles) net earnings of $127.5 million, or diluted earnings per share of $1.22 versus first quarter 2023 net earnings of $197.8 million, or $1.89 per diluted share.
Abbott Laboratories (ABT) reported first quarter results that topped Wall Street estimates on both the top and bottom lines. The healthcare products company also raised the lower end of its full-year earnings guidance range. Yahoo Finance's Anjalee Khemlani breaks down the results in the video above. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.
Elevance Health (ELV) delivered earnings and revenue surprises of 0.95% and 0.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Abbott Laboratories raised the lower end of its annual profit forecast as
Abbott Laboratories raised the lower end of its annual profit forecast as
Abbott Laboratories raised the lower end of its annual profit forecast as
Abbott Laboratories raised the lower end of its annual profit forecast as
Abbott Laboratories raised the lower end of its annual profit forecast as
Abbott Laboratories raised the lower end of its annual profit forecast as